{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T23:43:34Z","timestamp":1778975014083,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.jpsychires.2012.01.022","type":"journal-article","created":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T10:46:46Z","timestamp":1329562006000},"page":"622-629","source":"Crossref","is-referenced-by-count":19,"title":["T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period"],"prefix":"10.1016","volume":"46","author":[{"given":"Takashi","family":"Uehara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomiki","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadasu","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Iwakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Kurachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2012.01.022_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-007-0729-8","volume":"192","author":"Abekawa","year":"2007","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0301-0082(03)00112-6","article-title":"Hippocampal modulation of sensorimotor processes","volume":"70","author":"Bast","year":"2003","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s002130100775","article-title":"Hyperactivity, decreased startle reactivity, and disrupted prepulse inhibition following disinhibition of the rat ventral hippocampus by the GABA(A) receptor antagonist picrotoxin","volume":"156","author":"Bast","year":"2001","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0920-9964(96)00122-3","article-title":"Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics","volume":"24","author":"Beasley","year":"1997","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0006-3223(02)01360-4","article-title":"Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins","volume":"52","author":"Beasley","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib6","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1523\/JNEUROSCI.19-11-04449.1999","article-title":"Glutamate acting at NMDA receptors stimulates embryonic cortical neuronal migration","volume":"19","author":"Behar","year":"1999","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1126\/science.1148045","article-title":"Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase","volume":"318","author":"Behrens","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","article-title":"GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder","volume":"25","author":"Benes","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archpsyc.1992.01820030038005","article-title":"Gating and habituation of the startle reflex in schizophrenic patients","volume":"49","author":"Braff","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1176\/ajp.156.4.596","article-title":"Symptom correlates of prepulse inhibition deficits in male schizophrenic patients","volume":"156","author":"Braff","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2007.05.005","article-title":"Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism","volume":"97","author":"Braun","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0006-3223(99)00153-5","article-title":"Epidemiology and natural history of schizophrenia","volume":"46","author":"Bromet","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib13","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","article-title":"Models of schizophrenia in humans and animals based on inhibition of NMDA receptors","volume":"32","author":"Bubenikova-Valesova","year":"2008","journal-title":"Neuroscience and Biobehavioural Reviews"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib14","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMra035458","article-title":"Schizophrenia","volume":"349","author":"Freedman","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuint.2005.08.012","article-title":"T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons","volume":"48","author":"Fukushima","year":"2006","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbrc.2011.03.091","article-title":"T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice","volume":"407","author":"Fukushima","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.31887\/DCNS.2006.8.1\/mgeyer","article-title":"Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?","volume":"8","author":"Geyer","year":"2006","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib20","article-title":"NMDA receptors, cognition and schizophrenia \u2013 testing the validity of the NMDA receptor hypofunction hypothesis","author":"Gilmour","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1469-8986.1975.tb01284.x","article-title":"Presidential Address, 1974. The more or less startling effects of weak prestimulation","volume":"12","author":"Graham","year":"1975","journal-title":"Psychophysiology"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.105.083543","article-title":"A\u00a0novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons","volume":"314","author":"Hirata","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1121\/1.1910776","article-title":"Acoustic and temporal factors in the evocation of startle","volume":"43","author":"Hoffman","year":"1968","journal-title":"Journal of Acoustical Society of America"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s002130051017","article-title":"Picrotoxin in the medial prefrontal cortex impairs sensorimotor gating in rats: reversal by haloperidol","volume":"144","author":"Japha","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1476-5381.2009.00141.x","article-title":"T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-beta peptide","volume":"157","author":"Kimura","year":"2009","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-4328(97)02296-1","article-title":"The acoustic startle response in rats\u2013circuits mediating evocation, inhibition and potentiation","volume":"89","author":"Koch","year":"1997","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8096653","article-title":"Modulation of neuronal migration by NMDA receptors","volume":"260","author":"Komuro","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1440-1819.2003.01072.x","article-title":"Pathogenesis of schizophrenia: part I. Symptomatology, cognitive characteristics and brain morphology","volume":"57","author":"Kurachi","year":"2003","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1440-1819.2003.01073.x","article-title":"Pathogenesis of schizophrenia: part II. Temporo-frontal two-step hypothesis","volume":"57","author":"Kurachi","year":"2003","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(00)00111-2","article-title":"Catching up on schizophrenia: natural history and neurobiology","volume":"28","author":"Lewis","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0920-9964(99)00198-X","article-title":"The role of cognition in vocational functioning in schizophrenia","volume":"45","author":"McGurk","year":"2000","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0079-6123(08)00909-6","article-title":"In\u00a0vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems","volume":"172","author":"Meltzer","year":"2008","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib36","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1248\/bpb.32.1576","article-title":"Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood","volume":"32","author":"Nakatani-Pawlak","year":"2009","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/hipo.20281","article-title":"Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats","volume":"17","author":"Nguyen","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib38","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2005.08.029","article-title":"A\u00a0pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities","volume":"59","author":"Rujescu","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bjp.0703171","article-title":"Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory","volume":"130","author":"Schroeder","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neulet.2003.10.028","article-title":"Role of the medial prefrontal cortex in N-methyl-D-aspartate receptor antagonist induced sensorimotor gating deficit in rats","volume":"355","author":"Schwabe","year":"2004","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-007-1057-8","article-title":"T-817MA, a novel neurotrophic compound, ameliorates phencyclidine-induced disruption of sensorimotor gating","volume":"197","author":"Seo","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.biopsych.2004.11.031","article-title":"Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia","volume":"57","author":"Stefani","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s12325-008-0102-2","article-title":"Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics","volume":"25","author":"Sumiyoshi","year":"2008","journal-title":"Advances in Therapy"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib45","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1176\/appi.ajp.158.10.1722","article-title":"Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment","volume":"158","author":"Sumiyoshi","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","article-title":"Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges","volume":"156","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib47","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/archpsyc.63.12.1325","article-title":"Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function","volume":"63","author":"Swerdlow","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0306-4522(99)00528-X","article-title":"Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats: a parametric assessment","volume":"96","author":"Swerdlow","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopsych.2004.10.019","article-title":"Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains","volume":"57","author":"Torrey","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00213-009-1527-2","article-title":"Long-term effects of neonatal MK-801 treatment on prepulse inhibition in young adult rats","volume":"206","author":"Uehara","year":"2009","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.brainres.2010.07.013","article-title":"Neonatal exposure to MK-801, an N-methyl-d-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats","volume":"1352","author":"Uehara","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib52","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.102.041798","article-title":"Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic","volume":"304","author":"Wang","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib53","series-title":"Psychopharmacology: the forth generation of progress","first-page":"1171","article-title":"Neurodevelopmental perspectives on schizophrenia","author":"Weinberger","year":"1995"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib54","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0091-3057(02)00936-X","article-title":"Prepulse inhibition in rats with temporary inhibition\/inactivation of ventral or dorsal hippocampus","volume":"73","author":"Zhang","year":"2002","journal-title":"Pharmacology Biochemistry & Behavior"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00188-8","article-title":"A\u00a0selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia","volume":"55","author":"Zhang","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.01.022_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2006.05.010","article-title":"Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in\u00a0vivo microdialysis","volume":"86","author":"Zuo","year":"2007","journal-title":"Pharmacology Biochemistry & Behavior"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T21:03:11Z","timestamp":1686776591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395612000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0022395612000337"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2012.01.022","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}